CAR-T ICU 2019 | CRS: from low to high grade
Sandrine Valade, MD, Saint-Louis University Hospital, Paris, France, explains treatment approaches for patients with cytokine release syndrome (CRS), depending on the severity. She also discusses the potential of genetic predisposition to CRS, opening a new field of research. This interview took place at the CAR-T Cell Therapy and the ICU meeting in London, UK, which was organized by EuroCARTForce.
Get great new content delivered to your inboxSign up